ReleaseWire Connect

An investor, who purchased shares of MiMedx Group Inc (NASDAQ:MDXG), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by MiMedx Group Inc in connection with certain allegedly false and misleading statements made between March 15, 2013 and September 4, 2013.

An investigation on behalf of investors of Unilife Corp (NASDAQ:UNIS) shares over potential securities laws violations by Unilife Corp and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors in shares of HCA Holdings Inc (NYSE:HCA) was announced concerning whether certain HCA Holdings officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of investors in shares of Chemed Corporation (NYSE:CHE) was announced concerning whether certain Chemed officers and directors possibly breached their fiduciary duties in connection with certain statements.

A deadline is coming up on September 23, 2013 in the lawsuit filed for investors of JAKKS Pacific, Inc. (NASDAQ:JAKK) over alleged securities laws violations by JAKKS Pacific.

An investigation on behalf of current long-term stockholders of shares of RPM International Inc. (NYSE:RPM) was announced concerning whether certain RPM International officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investor, who currently hold shares of TMS International Corp. (NYSE:TMS), filed a lawsuit in effort to halt the proposed takeover of TMS International Corp. by The Pritzker Organization, LLC for $17.50 per NYSE:TMS share.

An investigation for current long-term investors in shares of Kimball International Inc (NASDAQ:KBALB) over potential wrongdoing by certain officers and directors of Kimball International Inc was announced and current long-term NASDAQ:KBALB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

An investor, who currently hold shares of Hi-Tech Pharmacal Co. (NASDAQ:HITK) , filed a lawsuit in effort to halt the proposed takeover of Hi-Tech Pharmacal Co. by Akorn, Inc.for $43.50 per NASDAQ:HITK share.

An investigation on behalf of investors, who currently hold shares of Kaydon Corporation (NYSE:KDN) shares, was announced concerning whether the takeover of Kaydon Corporation by AB SKF for $35.50 per NYSE:KDN share is unfair to Kaydon stockholders.